Anhui Anke Biotechnology (Group) Co (SZSE:300009) LT-Debt-to-Total-Asset : 0.01 (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Anhui Anke Biotechnology (Group) Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.01.

Anhui Anke Biotechnology (Group) Co's long-term debt to total assets ratio increased from Mar. 2023 (0.01) to Mar. 2024 (0.01). It may suggest that Anhui Anke Biotechnology (Group) Co is progressively becoming more dependent on debt to grow their business.

Anhui Anke Biotechnology (Group) Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co LT-Debt-to-Total-Asset Chart

Anhui Anke Biotechnology (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

Anhui Anke Biotechnology (Group) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	0.01

Anhui Anke Biotechnology (Group) Co LT-Debt-to-Total-Asset Calculation

Anhui Anke Biotechnology (Group) Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	47.817	/	4950.76
	=	0.01

Anhui Anke Biotechnology (Group) Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	46.161	/	5126.706
	=	0.01

Anhui Anke Biotechnology (Group) Co (SZSE:300009) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Anhui Anke Biotechnology (Group) Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088

Website

http://www.ankebio.com

Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Headlines

No Headlines